(-)-Epicatechin and Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Pulmonary Arterial Hypertension
Related studies linked through entity extraction aliases.
To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension
- Status
- TERMINATED
- Phase
- N/A
Iron Status and Hypoxic Pulmonary Vascular Responses
- Status
- COMPLETED
- Phase
- NA
Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
- Status
- COMPLETED
- Phase
- PHASE3
Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)
- Status
- TERMINATED
- Phase
- N/A
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
- Status
- COMPLETED
- Phase
- NA
Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE
- Status
- UNKNOWN
- Phase
- PHASE2
Tyvaso Dosing and Titration Evaluation: TyTRATE Registry
- Status
- COMPLETED
- Phase
- N/A
A Rising Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics of MK-8892 (MK-8892-001)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)
- Status
- TERMINATED
- Phase
- PHASE1
Patient Reported Outcomes in Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- N/A
Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome
- Status
- TERMINATED
- Phase
- PHASE3
Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)
- Status
- TERMINATED
- Phase
- PHASE2
Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2